Poor Ovarian Reserve
7
1
1
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
14%
1 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (7)
The Role of Ovarian PRP Therapy in Poseidon Poor Responders Women Undergoing ICSI Cycle
Ovarian PRP Injections for Improved Embryo Quality Using Embryo Quality Score
Growth Hormone For Poor Ovarian Reserve Patients in ICSI Trials
Autologous Intraovarian Platelet Rich Plasma Treatment in Women With Poor Ovarian Response
Dual Trigger in the Final Oocyte Maturation in Poor Ovarian Responders
Effect of Growth Hormone Injection on the IVF/ICSI Outcome of Patients With Poor Ovarian Reserve.
Growth Hormone for Poor Responders in in Vitro Fertilization (IVF)